We review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.
Courtney Moc, PharmD, MS
Advertisement
Articles by Courtney Moc, PharmD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Reductions in Funding, Personnel Will Leave US Less Prepared for Future Infectious Disease Outbreaks
2
Invivyd doses first participants in phase 3 COVID-19 trial of VYD2311
3
ASM Initiative Aims to Advance Phage Therapy for Drug-Resistant Infections
4
Challenges to Adopting New Therapeutics: Familiarity, Diagnostics, and Real-World Use in Persistent Bacteremia
5